Asthma, bronchial hyperreactivity and mediator release in children with birch pollinosis. ECP and EPX levels are not related to bronchial hyperreactivity

Clinical and Experimental Allergy

Volumn 27, Issue 5, 1997, Pages 530-539

  Ferdousi, H A ^a   Dreborg, S ^b  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b Voksentoppen   (Norway)

Author keywords

asthma; conjunctival provocation test; methacholine bronchial provocation test; peak expiratory flow rate; pollinosis; serum eosinophil cationic protein; serum eosinophil protein X; serum myeloperoxidase; skin prick test; visual analogue scale

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; MYELOPEROXIDASE;

ADOLESCENT; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CHILD; CLINICAL ARTICLE; CONJUNCTIVA EPITHELIUM; FEMALE; HUMAN; INFLAMMATORY CELL; LEUKOCYTE; MALE; MEDIATOR RELEASE; PEAK EXPIRATORY FLOW; PHYSICAL ACTIVITY; POLLEN ALLERGY; PRICK TEST; PRIORITY JOURNAL; PROVOCATION TEST; SEASONAL VARIATION; SKIN TEST;

ADOLESCENT; ASTHMA; BLOOD PROTEINS; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; CHILD; CHYMASES; CONJUNCTIVA; EOSINOPHIL GRANULE PROTEINS; EOSINOPHIL-DERIVED NEUROTOXIN; FEMALE; HUMANS; INFLAMMATION; MALE; METHACHOLINE CHLORIDE; PEAK EXPIRATORY FLOW RATE; PEROXIDASE; POLLEN; RIBONUCLEASES; SEASONS; SERINE ENDOPEPTIDASES; SKIN TESTS; TREES; TRYPTASES;

EID: 0030991635     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.1997.tb00741.x     Document Type: Article

References (33)

1. International Consensus Report on Diagnosis and Management of Asthma. Allergy 1992; 47: Suppl. 13:1-5.
2. Rak S, Löwhagen O, Venge P. The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen allergic patients. J Allergy Clin Immunol 1988: 82:470-80.
3. Carlsson M, Håkansson L, Kämpe M, Stålenheim G, Peterson C, Venge P. Degranualation of eosinophils from pollen-atopic patients with asthma is increased during the pollen season. J Allergy Clin Immunol 1992; 89:131-9.
4. Zimmerman B. Clinical experience with the measurement of ECP: usefulness in the management of children with asthma. Clinical and Experimental Allergy 1993; 23:8-12.
5. Chapman ID, Foster A, Morley J. The relationship between inflammation and hyperreactivity of the airways in asthma. Clin Exp Allergy 1993; 23:168-71.
6. Björnsson E, Janson C, Håkansson L, Enander I, Venge P, Boman G. Serum eosinophil cationic protein in relation to bronchial asthma in a young Swedish population. Allergy 1994; 49:730-36.
7. Jacobsen L, Dreborg S, Möller C, Valovirta E, Wahn U, Urbanek R. Bronchial hyperreactivity in children suffering from hayfever caused by allergy to pollen. Allergy 1993; 48:102.
8. Østerballe O, Weeke B. A new lancet for skin prick testing. Allergy 1979; 34:209-212.
9. Dreborg S, Frew A. (Eds.) Position Paper. Allergen standardization and skin tests. Allergy 1993; 47: Suppl. 14:48-82.
10. Dreborg S. The batch to batch variation of the potency of dog and cat allergen coated needles (Phazet®). Evaluation by skin prick testing. Allergy 1993; 47:373-6.
11. Dreborg S. Conjunctival provocation test (CPT). Allergy 1985; 40: Suppl 4:66-7.
12. Dreborg S, Einarsson R, Lau S, Munir AKM, Wahn U. Letter to the Editor of Allergy. Sampling of dust for analysis of allergens. Allergy 1995; 50:188-9.
13. Peterson CGB, Enander I, Nystrand J, Anderssson AS, Nilsson L, Venge P. Radioimmunoassay of human eosinophil cationic protein (ECP) by an improved method. Establishment of normal levels in serum and turn over in vivo. Clin Exp Allergy 1991; 21:561-7.
14. Olofsson T, Olsson I, Venge P, Elgefors B. Serum myeloperoxidase and lactoferrin in neutropenia. Scand J Haematol 1977; 18:73-80.
15. Pipkorn U. Pharmacological influence of anti-allergic medication on in vivo allergen testing. Allergy 1988; 43:81-6.
16. Munir AKM, Einarsson R, Dreborg S. Allergens in school dust. I. The amount of major cat (FeI d 1) and dog (Can f I) dust from Swedish schools is high enough to probably induce symptoms in most astmatic children sensitized to cat or dog. J Allergy Clin Immunol 1993; 91:1067-74.
17. Einarsson R, Munir AKM, Dreborg S. Allergens in school dust. II. Major mite (Der p I and Der f I) allergens in dust from Swedish schools. J Allergy Clin Immunol 1995; 95:1049-53.
18. Cockcroft DW. Mechanism of perennial allergic asthma. Lancet 1983; ii:253-6.
19. Platts Mills T.A.E, Mitchell E.B, Nock P, Tovey E.R, Moszoro H, Wilkins S.R. Reduction of bronchial hyperreactivity during prolonged allergen avoidance. Lancet 1982; ii:675-7.
20. Yli-Paunula E, Rantio-Lehtimäki. Birch-pollen antigenic activity of settled dust in rural and urban homes. Allergy 1995; 50:303-7.
21. Dreborg S. Allergen levels causing sensitisation, bronchial hyperreactivity and asthma. Pediatric Allergy and Immunology 1995; 6 Suppl: 22-6.
22. Munir AKM, Einarsson R, Dreborg S. Major mite (Der p I, Der f I), cat (Fel d I) and dog (Can f I) allergens in dust from Swedish Day-care centers. Clin Exp Allergy 1995; 25:119-26.
23. Croner S, Kjellman N-IM. Natural history of bronchial asthma in childhood - a prospective study from birth to 14 years of age. Allergy 1992; 47:150-7.
24. Gustavsson PM, Kjellman N-IM. Oesophageal symptoms and asthma. Trigger factors in asthmatic children and adolescents. In: Gustafsson PM: Oesophageal function, acid reflux and bronchopulmonary disease. A study on children and adolescents with asthma and cystic fibrosis, Linköping University Medical Dissertation no. 238, 1991:71-83.
25. Munir AKM, Einarsson R, Kjellman N-IM, Björkstén B. Mite (Der p. 1, Der f 1) and cat (Fel d 1) allergens in homes of babies with a family history of allergy. Allergy 1993; 43:158-63.
26. Kuehr J, Frischer T, Meinert R, Barth R, Forster J, Schraub S, Urbanek R, Karmaus W. Mite allergen exposure is a risk for the incidence of specific sensitization. J Allergy Clin Immunol 1994; 94:44-52.
27. 1 in the monitoring of asthmatic subjects at an outpatient clinic. Chest 1994; 106:1419-26.
28. Dreborg S, Agrell B, Foucard T, Kjellman N-IM, Koivikko A, Nilsson S. A Double-Blind Multi- center Immunotherapy Trial in Children, Using a Purified and Standardized Cladosporium herbarum Preparation. I. Clinical Results. Allergy 1986; 41:131-40.
29. Mailing HJ, Dreborg S, Weeke B. Diagnosis and immunotherapy in mould allergy. III. Diagnosis of Cladosporium allergy by means of symptom score, bronchial provocation test, skin prick test, RAST, CRIE and histamine release. Allergy 1986; 41:57-67.
30. Dreborg S, Björksten B, Kjellman N-IM, Rimas M. Diagnosis of rhino-conjunctivitis (RC) by history (CH), skin prick test (SPT) and conjunctival provocation tests. Discussion on definition of disease. J Allergy Clin Immunol 1989; 83:265.
31. Boner A L, Peroni D G, Piacentini G L, and Venge P. Influence of allergen avoidance at high altitude on serum markers of eosinophil activation in children with allergic asthma. Clin Exp Allergy 1993; 23:1021-6.
32. Niggemann B, Kleinau I, Schmitt M, Wahn U. Twenty-four-hour time course of eosinophil granule proteins ECP and EPX during bronchial allergen challenges in serum of asthmatic children. Allergy 1994; 49:74-80.
33. Pedersen B, Dahl R, Larsen BB, Venge P. The effect of salmeterol on the early and late-phase reaction to bronchial allergen and postchallenge variation in bronchial reactivity, blood eosinophils, serum eosinophil cationic protein, and serum eosinophil protein X. Allergy 1993; 48:377-82.